MONTENEGRO SKIN TEST AND AGE OF SKIN LESION AS PREDICTORS OF TREATMENT FAILURE IN CUTANEOUS LEISHMANIASIS

Authors

  • Liliane de Fátima Antonio Instituto de Pesquisa Clínica Evandro Chagas (IPEC)/Fiocruz; Laboratório de Vigilância em Leishmanioses (Lab VigiLeish)
  • Aline Fagundes Instituto de Pesquisa Clínica Evandro Chagas (IPEC)/Fiocruz; Laboratório de Vigilância em Leishmanioses (Lab VigiLeish)
  • Raquel Vasconcellos Carvalhaes Oliveira Instituto de Pesquisa Clínica Evandro Chagas (IPEC)/Fiocruz; Laboratório de Epidemiologia Clínica (Lab. EpiClin)
  • Priscila Garcia Pinto Instituto de Pesquisa Clínica Evandro Chagas (IPEC)/Fiocruz; Laboratório de Vigilância em Leishmanioses (Lab VigiLeish)
  • Sandro Javier Bedoya-Pacheco Instituto de Pesquisa Clínica Evandro Chagas (IPEC)/Fiocruz; Laboratório de Vigilância em Leishmanioses (Lab VigiLeish)
  • Érica de Camargo Ferreira e Vasconcellos Instituto de Pesquisa Clínica Evandro Chagas (IPEC)/Fiocruz; Laboratório de Vigilância em Leishmanioses (Lab VigiLeish)
  • Maria Cláudia Valete-Rosalino Federal University of Rio de Janeiro; Otorhinolaryngology and Ophthalmology Department
  • Marcelo Rosandiski Lyra Instituto de Pesquisa Clínica Evandro Chagas (IPEC)/Fiocruz; Laboratório de Vigilância em Leishmanioses (Lab VigiLeish)
  • Sônia Regina Lambert Passos Instituto de Pesquisa Clínica Evandro Chagas (IPEC)/Fiocruz; Laboratório de Epidemiologia Clínica (Lab. EpiClin)
  • Maria Inês Fernandes Pimentel Instituto de Pesquisa Clínica Evandro Chagas (IPEC)/Fiocruz; Laboratório de Vigilância em Leishmanioses (Lab VigiLeish)
  • Armando de Oliveira Schubach

Abstract

A case-control study was conducted to examine the association among the Montenegro skin test (MST), age of skin lesion and therapeutic response in patients with cutaneous leishmaniasis (CL) treated at Evandro Chagas National Institute of Infectious Diseases (INI), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil. For each treatment failure (case), two controls showing skin lesion healing following treatment, paired by sex and age, were randomly selected. All patients were treated with 5 mg Sb5+/kg/day of intramuscular meglumine antimoniate (Sb5+) for 30 successive days. Patients with CL were approximately five times more likely to fail when lesions were less than two months old at the first appointment. Patients with treatment failure showed less intense MST reactions than patients progressing to clinical cure. For each 10 mm of increase in MST response, there was a 26% reduction in the chance of treatment failure. An early treatment - defined as a treatment applied for skin lesions, which starts when they are less than two months old at the first appointment -, as well as a poor cellular immune response, reflected by lower reactivity in MST, were associated with treatment failure in cutaneous leishmaniasis.

Downloads

Download data is not yet available.

Downloads

Published

2014-09-01

Issue

Section

Leishmaniasis

How to Cite

Antonio, L. de F., Fagundes, A., Oliveira, R. V. C., Pinto, P. G., Bedoya-Pacheco, S. J., Vasconcellos, Érica de C. F. e, Valete-Rosalino, M. C., Lyra, M. R., Passos, S. R. L., Pimentel, M. I. F., & Schubach, A. de O. (2014). MONTENEGRO SKIN TEST AND AGE OF SKIN LESION AS PREDICTORS OF TREATMENT FAILURE IN CUTANEOUS LEISHMANIASIS . Revista Do Instituto De Medicina Tropical De São Paulo, 56(5), 375-380. https://journals.usp.br/rimtsp/article/view/87530